<unk>  is used in the treatment of many types of supraventricular tachycardias, including AV nodal re-entrant tachycardia (AVNRT) and Wolff-Parkinson-White syndrome (WPW). It also has limited use in the treatment of certain forms of ventricular tachycardia (VT). In particular,<unk>  has been useful in the treatment of ventricular tachycardias that are not in the setting of an acute ischemic event. It has use in the treatment of right ventricular outflow tract (RVOT) tachycardia and in the suppression of arrhythmias in arrhythmogenic right ventricular dysplasia (ARVD). Studies (notably the Cardiac Arrhythmia Suppression Trial) have shown an increased mortality when<unk>  is used to suppress ventricular extrasystoles in the setting of acute myocardial infarction. In individuals suspected of having the Brugada syndrome, the administration of<unk>  may help reveal the ECG findings that are characteristic of the disease process. This may help make the diagnosis of the disease in equivocal cases.<unk>  has been introduced into the treatment of arrhythmias in children. In the long-term,<unk>  seems to be safe in people with a healthy heart with no signs of left ventricular hypertrophy, ischemic heart disease, or heart failure.
Flecainide
Tocainide
Procainamide
Acecainide
Amiodarone
Ibutilide
Verapamil
Dofetilide